Can you wear an ambulatory (portable) insulin pump during a Hepatobiliary Iminodiacetic Acid (HIDA) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Wear an Ambulatory Insulin Pump During a HIDA Scan?

No, you should not wear an insulin pump during a HIDA scan—the pump must be removed before the procedure, though the specific imaging modality (nuclear medicine scintigraphy) does not pose the same electromagnetic interference risks as MRI. While HIDA scans use gamma cameras rather than magnetic fields, institutional protocols typically require removal of insulin pumps for radiological procedures to maintain standardized safety practices. 1, 2

Why Insulin Pumps Are Removed for Imaging Procedures

  • Standard radiological safety protocols recommend removing insulin pumps for CT/MRI and body imaging procedures, even though HIDA scans (nuclear medicine studies) do not generate electromagnetic fields like MRI does. 1, 2

  • The primary concern with MRI specifically is that electromagnetic fields can cause pump malfunction, unpredictable insulin delivery (either excessive or interrupted), and potential heating of metal components in the infusion set. 1

  • For HIDA scans, the removal recommendation stems from institutional standardization of imaging protocols rather than direct electromagnetic interference, as the procedure uses radiotracer imaging with gamma cameras. 2

Critical Management Protocol When Removing the Pump

Before the HIDA Scan (30 Minutes Prior)

  • Start intravenous insulin infusion at least 30 minutes before disconnecting the pump, initially at the patient's programmed hourly basal rate. 1, 2

  • This prevents rapid hyperglycemia and ketosis, which can develop within 1 hour of pump disconnection since pumps use only rapid-acting insulin with no long-acting depot. 2

  • Monitor blood glucose hourly during the transition to ensure adequate control. 1

During the HIDA Scan

  • The pump remains completely removed from the patient during the imaging procedure. 1, 2

  • Continue IV insulin infusion, adjusting based on blood glucose monitoring to maintain levels between 6-10 mmol/L (108-180 mg/dL). 1, 2

After the HIDA Scan (2-Hour Overlap)

  • Reconnect the pump and run it alongside IV insulin for 2 hours to re-establish a subcutaneous insulin depot before discontinuing IV insulin. 1, 2

  • Monitor blood glucose hourly during this transition to prevent hyperglycemia or hypoglycemia. 1

Important Clinical Caveats

  • For urgent/emergency HIDA scans where 30-minute overlap isn't feasible, start IV insulin immediately upon pump removal without delay to prevent diabetic ketoacidosis. 1

  • Disconnection, occlusion, or interruption of the pump can cause insulin deficiency within 1 hour and absolute deficiency within 4 hours, creating significant risk for hyperglycemia and ketosis since pumps deliver only rapid-acting insulin. 2

  • Continuous glucose monitors (CGMs) should also be removed for the procedure unless explicitly verified as safe by the manufacturer, though this is less critical for HIDA scans than for MRI. 1

  • The acceptable blood glucose range is 4-12 mmol/L (72-216 mg/dL), with target range of 6-10 mmol/L (108-180 mg/dL) during the perioperative period. 2

Radiation Exposure Considerations

  • While one small study showed insulin pumps could withstand significant CT radiation exposure (at least 8576 mrem from 34 CT scans) without major malfunction 3, this does not change the recommendation to remove pumps for imaging procedures, as institutional protocols prioritize standardized safety practices. 1, 2

  • HIDA scans involve much lower radiation exposure than multiple CT scans, but removal remains standard practice. 3

References

Guideline

Insulin Pump Management for MRI Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insulin Pump Therapy in Diabetes Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.